P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrestA. Shamseddine, Yusuf A. Hannun|Cell Death and Disease|2015Cited by 89
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapiesA. Shamseddine, Adam M. Schmitt, Valery Chávez et al.|The Journal of Experimental Medicine|2022Cited by 26